Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01980771 · ClinicalTrials.gov registry record · NA
Barbershop Talk: HIV Prevention for African American Heterosexual Men
A NA study, sponsored by State University of New York - Downstate Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 860
- Enrollment target
NCT01980771: Completed NA study, sponsored by State University of New York - Downstate Medical Center.
NCT01980771 is a NA study that has completed, run by State University of New York - Downstate Medical Center. The registered enrollment target is 860 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01980771, a NA study, has completed, sponsored by State University of New York - Downstate Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 860 participants
- Enrollment target
Study Summary
This program utilizes a community-engaged research approach to implementing and evaluating a program that seeks to reduce sexual risk behavior among Black adult heterosexual men. The investigators aims are to assess the impact of this linguistically and culturally tailored HIV prevention program on the sexual risk of heterosexual, African American men aged 18 and older, to assess the intervention's impact on the more proximal social and psychosocial variables that the program is designed to change, and to identify key contextual level factors that may impact the intervention's impact across segments of this priority population.
Primary Outcome
Self-reported sexual behavior is the number of participants that report any unprotected anal and/or vaginal sex in the past ninety days.
Interventions
- BEHAVIORAL BTWB intervention
- BEHAVIORAL Cancer prevention and screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-02-01 |
| Phase | NA |
What the finished NCT01980771 record still lists
NCT01980771 is an interventional study that assigns participants to a tested intervention. The registered 860 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 2 interventions - of which BTWB intervention is the first listed.
NCT01980771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01980771 about?
NCT01980771 is a clinical study titled "Barbershop Talk: HIV Prevention for African American Heterosexual Men". This program utilizes a community-engaged research approach to implementing and evaluating a program that seeks to reduce sexual risk behavior among Black adult heterosexual men. The investigators aims are to assess the impact of this linguistically and culturally tailored HIV prevention program on ...
What is the current status of trial NCT01980771?
This trial is currently completed. It is a NA study. The enrollment target is 860 participants. The study started on 2012-11. Estimated completion is 2017-02-01.
What interventions are being tested in trial NCT01980771?
The interventions under investigation include: BTWB intervention (BEHAVIORAL), Cancer prevention and screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT01980771?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01980771's enrollment target sits among peer trials
860 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia